KEAP1 and neoplasm: Nrf2 is activated in the tumor microenvironment by tumor suppressor genes BRCA1 and protein p21 via suppression of Keap1/Nrf2 complex formation, and is inhibited by oncogene Fyn-mediated degradation [122].